About 35% to 50 % of patients with metastatic disease in the Sentinel Lymph Node (SLN) has additional nodal metastases detected at the Completion Axillary Limph Nodes Dissection (CALND). To identify the individual patient’s risk for non-SLN metastases nine statistical methods were described in the recent literature: one from the Breast Service of Memorial Sloan- Kettering Cancer Center (MSKCC), one from Tenon Hospital (France), one from Cambridge (UK), one from Stanford (USA), the Saidi score, the Mayo nomogram and the MDA score (USA), and finally two tools described by Kohrt et al. The outcome of these tools is the predicted probability of Non-SLNs metastasis in positive SLN Biopsy.
Predicting non-sentinel-nodes status in patients with metastatic sentinel node: which nomogram? / Lombardi, Augusto; Maggi, Stefano; DI STEFANO, D; DI NAPOLI, Arianna; Amanti, Claudio; LO RUSSO, Marzia. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - STAMPA. - 8:3(2010), pp. 150-150. [10.1016/S1359-6349(10)70341-4]
Predicting non-sentinel-nodes status in patients with metastatic sentinel node: which nomogram?
LOMBARDI, Augusto;MAGGI, Stefano;DI NAPOLI, Arianna;AMANTI, Claudio;LO RUSSO, Marzia
2010
Abstract
About 35% to 50 % of patients with metastatic disease in the Sentinel Lymph Node (SLN) has additional nodal metastases detected at the Completion Axillary Limph Nodes Dissection (CALND). To identify the individual patient’s risk for non-SLN metastases nine statistical methods were described in the recent literature: one from the Breast Service of Memorial Sloan- Kettering Cancer Center (MSKCC), one from Tenon Hospital (France), one from Cambridge (UK), one from Stanford (USA), the Saidi score, the Mayo nomogram and the MDA score (USA), and finally two tools described by Kohrt et al. The outcome of these tools is the predicted probability of Non-SLNs metastasis in positive SLN Biopsy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
